In focus · trending topic

ILiAD Biotechnologies

2 stories · following the connections

ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones Including Positive Phase 1b Clinical Study Data

By Nasdaq OMXJul 5, 2017, 1:00 PM UTC

Phase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study Groups

By Nasdaq OMXFeb 19, 2016, 2:55 PM UTC